ELEVANCE HEALTH INC (ELV) Fundamental Analysis & Valuation

NYSE:ELV • US0367521038

Current stock price

376.63 USD
+13.89 (+3.83%)
At close:
374.75 USD
-1.88 (-0.5%)
After Hours:

This ELV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ELV Profitability Analysis

1.1 Basic Checks

  • ELV had positive earnings in the past year.
  • In the past year ELV had a positive cash flow from operations.
  • ELV had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ELV had a positive operating cash flow.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ELV has a better Return On Assets (4.17%) than 72.00% of its industry peers.
  • The Return On Equity of ELV (11.94%) is better than 79.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.16%, ELV is in line with its industry, outperforming 59.00% of the companies in the same industry.
  • ELV had an Average Return On Invested Capital over the past 3 years of 6.74%. This is in line with the industry average of 8.40%.
Industry RankSector Rank
ROA 4.17%
ROE 11.94%
ROIC 5.16%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ELV has a better Profit Margin (2.62%) than 64.00% of its industry peers.
  • In the last couple of years the Profit Margin of ELV has declined.
  • ELV has a Operating Margin (3.81%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of ELV has declined.
Industry RankSector Rank
OM 3.81%
PM (TTM) 2.62%
GM N/A
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ELV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
  • The number of shares outstanding for ELV has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ELV has less shares outstanding
  • The debt/assets ratio for ELV has been reduced compared to a year ago.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • ELV has a debt to FCF ratio of 4.94. This is a neutral value as ELV would need 4.94 years to pay back of all of its debts.
  • ELV has a Debt to FCF ratio of 4.94. This is comparable to the rest of the industry: ELV outperforms 60.00% of its industry peers.
  • ELV has a Debt/Equity ratio of 0.72. This is a neutral value indicating ELV is somewhat dependend on debt financing.
  • ELV has a Debt to Equity ratio (0.72) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.94
Altman-Z N/A
ROIC/WACC0.61
WACC8.48%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ELV Growth Analysis

3.1 Past

  • ELV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.26%.
  • The Earnings Per Share has been growing slightly by 6.12% on average over the past years.
  • ELV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.44%.
  • ELV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.32% yearly.
EPS 1Y (TTM)-10.26%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%5.1%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%1.49%

3.2 Future

  • ELV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.68% yearly.
  • Based on estimates for the next years, ELV will show a small growth in Revenue. The Revenue will grow by 2.68% on average per year.
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.68%
Revenue Next Year-2.7%
Revenue Next 2Y0.14%
Revenue Next 3Y1.81%
Revenue Next 5Y2.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

5

4. ELV Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.24, the valuation of ELV can be described as correct.
  • 90.00% of the companies in the same industry are more expensive than ELV, based on the Price/Earnings ratio.
  • ELV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
  • With a Price/Forward Earnings ratio of 12.75, ELV is valued correctly.
  • ELV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ELV is cheaper than 84.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.68. ELV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.24
Fwd PE 12.75
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ELV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ELV is cheaper than 69.00% of the companies in the same industry.
  • ELV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ELV is cheaper than 76.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.83
EV/EBITDA 11.38
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2
EPS Next 2Y-1.04%
EPS Next 3Y4.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ELV Dividend Analysis

5.1 Amount

  • ELV has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.45, ELV pays a better dividend. On top of this ELV pays more dividend than 92.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ELV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

  • The dividend of ELV is nicely growing with an annual growth rate of 12.23%!
  • ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ELV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)12.23%
Div Incr Years14
Div Non Decr Years14
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 28.97% of the earnings are spent on dividend by ELV. This is a low number and sustainable payout ratio.
  • ELV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.97%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ELV Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

NYSE:ELV (4/29/2026, 8:10:07 PM)

After market: 374.75 -1.88 (-0.5%)

376.63

+13.89 (+3.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength44.1
Industry Growth72.05
Earnings (Last)04-22
Earnings (Next)07-15
Inst Owners93.83%
Inst Owner Change0%
Ins Owners0.15%
Ins Owner Change12.62%
Market Cap82.73B
Revenue(TTM)200.41B
Net Income(TTM)5.24B
Analysts74.29
Price Target398.28 (5.75%)
Short Float %2.02%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Yearly Dividend6.82
Dividend Growth(5Y)12.23%
DP28.97%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.78%
Min EPS beat(2)6.46%
Max EPS beat(2)15.09%
EPS beat(4)3
Avg EPS beat(4)10.08%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)6
Avg EPS beat(8)3.81%
EPS beat(12)9
Avg EPS beat(12)3.03%
EPS beat(16)12
Avg EPS beat(16)2.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-2%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-2%
Max Revenue beat(4)1.66%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)6
Avg Revenue beat(12)0.58%
Revenue beat(16)9
Avg Revenue beat(16)0.65%
PT rev (1m)-1.91%
PT rev (3m)-1.58%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)4.89%
EPS NY rev (1m)0.07%
EPS NY rev (3m)-3.89%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-5.16%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-5.81%
Valuation
Industry RankSector Rank
PE 12.24
Fwd PE 12.75
P/S 0.41
P/FCF 12.83
P/OCF 10.88
P/B 1.88
P/tB 18.51
EV/EBITDA 11.38
EPS(TTM)30.78
EY8.17%
EPS(NY)29.55
Fwd EY7.84%
FCF(TTM)29.36
FCFY7.8%
OCF(TTM)34.62
OCFY9.19%
SpS912.39
BVpS199.86
TBVpS20.35
PEG (NY)N/A
PEG (5Y)2
Graham Number372.042 (-1.22%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 11.94%
ROCE 6.49%
ROIC 5.16%
ROICexc 5.62%
ROICexgc 10.13%
OM 3.81%
PM (TTM) 2.62%
GM N/A
FCFM 3.22%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
ROICexc(3y)7.29%
ROICexc(5y)7.65%
ROICexgc(3y)13.44%
ROICexgc(5y)14.29%
ROCE(3y)8.45%
ROCE(5y)8.91%
ROICexgc growth 3Y-7.91%
ROICexgc growth 5Y-6.83%
ROICexc growth 3Y-6.71%
ROICexc growth 5Y-5.47%
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 4.94
Debt/EBITDA 3.44
Cap/Depr 75.64%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 83.03%
Profit Quality 123.02%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.48%
ROIC/WACC0.61
Cap/Depr(3y)78.87%
Cap/Depr(5y)77.78%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.71%
Profit Quality(3y)81.36%
Profit Quality(5y)97.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.26%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%5.1%
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.68%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%1.49%
Revenue Next Year-2.7%
Revenue Next 2Y0.14%
Revenue Next 3Y1.81%
Revenue Next 5Y2.68%
EBIT growth 1Y-16.07%
EBIT growth 3Y-1.51%
EBIT growth 5Y1.02%
EBIT Next Year-1.32%
EBIT Next 3Y5.18%
EBIT Next 5Y7.75%
FCF growth 1Y180.92%
FCF growth 3Y-24.06%
FCF growth 5Y-19.97%
OCF growth 1Y113.03%
OCF growth 3Y-20.06%
OCF growth 5Y-16.69%

ELEVANCE HEALTH INC / ELV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to ELV.


Can you provide the valuation status for ELEVANCE HEALTH INC?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (ELV) stock?

ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for ELV stock?

The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (ELV) is 12.24 and the Price/Book (PB) ratio is 1.88.


How sustainable is the dividend of ELEVANCE HEALTH INC (ELV) stock?

The dividend rating of ELEVANCE HEALTH INC (ELV) is 7 / 10 and the dividend payout ratio is 28.97%.